{"id":2082,"date":"2026-04-10T08:27:30","date_gmt":"2026-04-10T05:27:30","guid":{"rendered":"https:\/\/merkezlaboratuvari.com\/test-listesi\/ace-angiotensin-converting-enzim-2\/"},"modified":"2026-09-01T23:55:47","modified_gmt":"2026-09-01T20:55:47","slug":"ace-angiotensin-converting-enzim","status":"publish","type":"page","link":"https:\/\/merkezlaboratuvari.com\/ar\/test-listesi\/ace-angiotensin-converting-enzim\/","title":{"rendered":"ACE (Angiotensin Converting Enzim)"},"content":{"rendered":"<h1>ACE (Angiotensin Converting Enzim)<\/h1>\n<h2>Laboratuvar Bilgileri<\/h2>\n<ul>\n<li><strong>Yeni Kod:<\/strong> BIO2459<\/li>\n<li><strong>SUT Kodu:<\/strong> L100880<\/li>\n<li><strong>Eski Kod:<\/strong> B\u01300003<\/li>\n<li><strong>Kategori:<\/strong> \u0643\u064a\u0645\u064a\u0627\u0621 \u062d\u064a\u0648\u064a\u0629<\/li>\n<li><strong>Numune T\u00fcr\u00fc:<\/strong> Serum<\/li>\n<li><strong>Numune Kab\u0131:<\/strong> Sar\u0131 Kapak<\/li>\n<li><strong>\u00c7al\u0131\u015fma G\u00fcn\u00fc:<\/strong> Her g\u00fcn<\/li>\n<li><strong>\u00d6nemli Kriter:<\/strong> \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.<\/li>\n<li><strong>Raporlama Tarihi:<\/strong> 3 g\u00fcn sonra 18:00<\/li>\n<\/ul>\n<h2>ACE (Angiotensin Converting Enzim) Testi Nedir?<\/h2>\n<p>ACE (Angiotensin Converting Enzim), laboratuvar ortam\u0131nda de\u011ferlendirilen bir biyokimya testidir. De\u011ferlendirme \u00e7o\u011fu zaman serum \u00f6rne\u011fi \u00fczerinden planlan\u0131r.<\/p>\n<p>ACE (Anjiotensin Konverting Enzim; Anjiotensin D\u00f6n\u00fc\u015ft\u00fcr\u00fcc\u00fc Enzim), renin-anjiotensin-aldosteron sisteminde (RAAS) anjiotensin I&#8217;i aktif formu olan anjiotensin II&#8217;ye d\u00f6n\u00fc\u015ft\u00fcren ve bradikinini inaktive eden bir enzimdir. Akci\u011fer endotelinde yo\u011fun olarak bulunur. Sarkoidoz ba\u015fta olmak \u00fczere gran\u00fclomat\u00f6z hastal\u0131klarda gran\u00fclom h\u00fccrelerinden (epiteloid h\u00fccreler) salg\u0131lanarak serum d\u00fczeyi y\u00fckselir.<\/p>\n<p>Bu testin klinik anlam\u0131; istem nedeni, hastan\u0131n yak\u0131nmalar\u0131, ya\u015f\u0131, e\u015flik eden hastal\u0131klar\u0131, kullan\u0131lan y\u00f6ntem ve di\u011fer laboratuvar bulgular\u0131 ile birlikte de\u011ferlendirilir. Bu nedenle sonu\u00e7, tek ba\u015f\u0131na de\u011fil, b\u00fct\u00fcnc\u00fcl t\u0131bbi \u00e7er\u00e7eve i\u00e7inde yorumlanmal\u0131d\u0131r.<\/p>\n<h2>ACE (Angiotensin Converting Enzim) Hangi Durumlarda \u0130stenir?<\/h2>\n<p>ACE (Angiotensin Converting Enzim) testi, hekim taraf\u0131ndan klinik gereklilik g\u00f6r\u00fclen durumlarda istenebilir. \u0130stem gerek\u00e7esi hastan\u0131n mevcut tablosuna g\u00f6re de\u011fi\u015febilir.<\/p>\n<ul>\n<li>Sarkoidoz tan\u0131s\u0131 ve hastal\u0131k aktivitesinin takibi<\/li>\n<li>Gran\u00fclomat\u00f6z hastal\u0131klar\u0131n ay\u0131r\u0131c\u0131 tan\u0131s\u0131<\/li>\n<li>Sarkoidoz tedavi yan\u0131t\u0131n\u0131n izlenmesi<\/li>\n<li>A\u00e7\u0131klanamayan lenfadenopati, \u00fcveit, eritema nodozum, hiperkalsemi de\u011ferlendirmesi<\/li>\n<li>Akci\u011fer infiltrasyonlar\u0131n\u0131n ay\u0131r\u0131c\u0131 tan\u0131s\u0131<\/li>\n<\/ul>\n<p>Ayn\u0131 test farkl\u0131 hastalarda farkl\u0131 klinik sorulara yan\u0131t aramak amac\u0131yla kullan\u0131labildi\u011fi i\u00e7in, nihai de\u011ferlendirme her zaman ki\u015fisel t\u0131bbi \u00f6yk\u00fc ve muayene bulgular\u0131 ile birlikte yap\u0131lmal\u0131d\u0131r.<\/p>\n<h2>ACE (Angiotensin Converting Enzim) Testi \u00d6ncesi Haz\u0131rl\u0131k<\/h2>\n<p>Haz\u0131rl\u0131k gereksinimi; testin t\u00fcr\u00fcne, numune yap\u0131s\u0131na ve laboratuvar\u0131n \u00e7al\u0131\u015fma kurallar\u0131na g\u00f6re de\u011fi\u015febilir. Test \u00f6ncesinde laboratuvar\u0131n ve hekimin verdi\u011fi talimatlar esas al\u0131nmal\u0131d\u0131r.<\/p>\n<ul>\n<li>A\u00e7l\u0131k genellikle gerekmez.<\/li>\n<li>ACE inhibit\u00f6r\u00fc (enalapril, ramipril, lisinopril vb.) kullan\u0131m\u0131 serum ACE d\u00fczeyini d\u00fc\u015f\u00fcr\u00fcr; hekim bilgilendirilmelidir.<\/li>\n<li>ARB (anjiotensin resept\u00f6r blokerleri) ila\u00e7lar ACE d\u00fczeyini etkilemez.<\/li>\n<li>18 ya\u015f\u0131ndan k\u00fc\u00e7\u00fcklerde referans de\u011ferler farkl\u0131d\u0131r (fizyolojik olarak y\u00fcksektir).<\/li>\n<\/ul>\n<p>Kullan\u0131lan ila\u00e7lar, takviyeler, yak\u0131n d\u00f6nemde ge\u00e7irilen hastal\u0131klar ve e\u015flik eden kronik durumlar sonucun yorumlanmas\u0131n\u0131 etkileyebilece\u011fi i\u00e7in sa\u011fl\u0131k profesyoneli ile payla\u015f\u0131lmal\u0131d\u0131r.<\/p>\n<h2>ACE (Angiotensin Converting Enzim) Testi Nas\u0131l Yap\u0131l\u0131r?<\/h2>\n<p>ACE (Angiotensin Converting Enzim) testi, uygun biyolojik \u00f6rnek al\u0131nd\u0131ktan sonra laboratuvar\u0131n belirledi\u011fi y\u00f6ntemle \u00e7al\u0131\u015f\u0131l\u0131r. Numunenin do\u011fru zamanda, uygun kapta ve uygun ta\u015f\u0131ma ko\u015fullar\u0131nda ula\u015ft\u0131r\u0131lmas\u0131 test kalitesi a\u00e7\u0131s\u0131ndan \u00f6nem ta\u015f\u0131r.<\/p>\n<ul>\n<li><strong>Numune T\u00fcr\u00fc:<\/strong> Serum<\/li>\n<li><strong>Numune Kab\u0131:<\/strong> Sar\u0131 Kapak<\/li>\n<li><strong>\u00c7al\u0131\u015fma G\u00fcn\u00fc:<\/strong> Her g\u00fcn<\/li>\n<li><strong>\u00d6nemli Kriter:<\/strong> \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.<\/li>\n<li><strong>Raporlama Tarihi:<\/strong> 3 g\u00fcn sonra 18:00<\/li>\n<\/ul>\n<ul>\n<li><strong>Numune tipi:<\/strong> Ven\u00f6z kan (serum)<\/li>\n<li><strong>Numune al\u0131m\u0131:<\/strong> Koldan ven\u00f6z kan al\u0131n\u0131r.<\/li>\n<li><strong>Y\u00f6ntem:<\/strong> Enzimatik (FAPGG substrat\u0131) veya spektrofotometrik y\u00f6ntem<\/li>\n<li><strong>Sonu\u00e7 s\u00fcresi:<\/strong> 1\u20133 g\u00fcn i\u00e7inde sonu\u00e7lan\u0131r.<\/li>\n<\/ul>\n<p>Baz\u0131 durumlarda \u00f6rnek kalitesi, numune miktar\u0131, ta\u015f\u0131ma s\u00fcresi veya teknik tekrar gereksinimi raporlama s\u00fcresini ve sonucun g\u00fcvenilirli\u011fini etkileyebilir.<\/p>\n<h2>ACE (Angiotensin Converting Enzim) Testi Ka\u00e7 G\u00fcnde \u00c7\u0131kar?<\/h2>\n<p>Mevcut laboratuvar bilgisine g\u00f6re bu test i\u00e7in raporlama s\u00fcresi: <strong>3 g\u00fcn sonra 18:00<\/strong> \u015feklindedir.<\/p>\n<p>Numunenin kabul zaman\u0131, laboratuvar\u0131n \u00e7al\u0131\u015fma plan\u0131, resmi tatiller veya gerekti\u011finde tekrar \u00e7al\u0131\u015fma gibi etkenler sonucu etkileyebilece\u011fi i\u00e7in en g\u00fcncel bilgi rapor tarihi \u00fczerinden de\u011ferlendirilmelidir.<\/p>\n<h2>Referans De\u011ferleri ve Sonu\u00e7lar\u0131n De\u011ferlendirilmesi<\/h2>\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Grup<\/th><th>De\u011fer Aral\u0131\u011f\u0131<\/th><\/tr><\/thead><tbody><tr><td>Yeti\u015fkin (>18 ya\u015f)<\/td><td>8\u201352 U\/L<\/td><\/tr><tr><td>\u00c7ocuk ve ad\u00f6lesan<\/td><td>Yeti\u015fkin de\u011ferlerinin 1,5\u20132 kat\u0131 olabilir<\/td><\/tr><\/tbody><\/table><\/figure>\n\n<p>> Not: Referans de\u011ferleri y\u00f6nteme ve laboratuvara g\u00f6re farkl\u0131l\u0131k g\u00f6sterebilir. ACE inhibit\u00f6r\u00fc kullanan hastalarda d\u00fczey bask\u0131lan\u0131r.<\/p>\n<p>Referans bilgileri; kullan\u0131lan y\u00f6ntem, ya\u015f grubu, biyolojik \u00f6rnek tipi ve laboratuvar standard\u0131na g\u00f6re de\u011fi\u015febilece\u011finden, rapor \u00fczerinde yer alan laboratuvar yorumu esas al\u0131nmal\u0131d\u0131r.<\/p>\n<h2>ACE (Angiotensin Converting Enzim) Sonucu Nas\u0131l Yorumlan\u0131r?<\/h2>\n<p>Test sonucu tek ba\u015f\u0131na kesin tan\u0131 koydurmaz. Sonu\u00e7; klinik bulgular, di\u011fer laboratuvar verileri ve gerekli g\u00f6r\u00fcld\u00fc\u011f\u00fcnde ek incelemeler ile birlikte de\u011ferlendirilir.<\/p>\n<h3>Y\u00fcksek ACE<\/h3>\n<p><strong>Sarkoidoz:<\/strong><\/p>\n<ul>\n<li>Aktif sarkoidozda hastalar\u0131n %40\u201390&#8217;\u0131nda y\u00fcksek bulunur<\/li>\n<li>Hastal\u0131k aktivitesi ile paralel seyreder<\/li>\n<li>Tedavi ile d\u00fc\u015fer; relaps ile tekrar y\u00fckselir<\/li>\n<li>Evre I\u2013II sarkoidozda daha s\u0131k y\u00fcksekken, evre IV&#8217;te (fibrotik) d\u00fc\u015f\u00fck olabilir<\/li>\n<\/ul>\n<p><strong>Di\u011fer gran\u00fclomat\u00f6z hastal\u0131klar:<\/strong><\/p>\n<ul>\n<li>T\u00fcberk\u00fcloz<\/li>\n<li>Lepra<\/li>\n<li>Histoplazmoz<\/li>\n<li>Berilioz<\/li>\n<li>Silikoz<\/li>\n<\/ul>\n<p><strong>Di\u011fer nedenler:<\/strong><\/p>\n<ul>\n<li>Gaucher hastal\u0131\u011f\u0131<\/li>\n<li>Hipertiroidizm<\/li>\n<li>Diabetes mellitus<\/li>\n<li>Karaci\u011fer hastal\u0131klar\u0131 (primer biliyer kolanjit, alkolik hepatit)<\/li>\n<li>Lenfoma<\/li>\n<li>\u0130diyopatik pulmoner fibrozis<\/li>\n<li>Amiloidoz<\/li>\n<\/ul>\n<h3>Normal veya D\u00fc\u015f\u00fck ACE<\/h3>\n<ul>\n<li>ACE inhibit\u00f6r\u00fc kullan\u0131m\u0131 (ila\u00e7 etkisi)<\/li>\n<li>\u0130naktif veya tedavi alt\u0131ndaki sarkoidoz<\/li>\n<li>Hipotiroidizm<\/li>\n<li>KOAH (baz\u0131 vakalarda)<\/li>\n<li>Sarkoidoz d\u0131\u015f\u0131 nedenli akci\u011fer hastal\u0131klar\u0131 (\u00e7o\u011funda normal)<\/li>\n<\/ul>\n<h3>Sarkoidozda Klinik Kullan\u0131m<\/h3>\n<ul>\n<li>ACE tek ba\u015f\u0131na sarkoidoz tan\u0131s\u0131 koymak i\u00e7in yeterli de\u011fildir (duyarl\u0131l\u0131k %40\u201390, \u00f6zg\u00fcll\u00fck %80\u201390).<\/li>\n<li>Tan\u0131 biyopsi ile do\u011frulanmal\u0131d\u0131r.<\/li>\n<li>ACE d\u00fczeyi hastal\u0131k aktivitesinin takibinde ve tedavi yan\u0131t\u0131n\u0131n izlenmesinde faydal\u0131d\u0131r.<\/li>\n<li>Normal ACE d\u00fczeyi sarkoidozu ekarte ettirmez.<\/li>\n<\/ul>\n<p>\u00d6zellikle s\u0131n\u0131rda, d\u00fc\u015f\u00fck d\u00fczeyli veya beklenmeyen sonu\u00e7larda klinik korelasyon gerekir. Gerekti\u011finde tekrar test, panel de\u011ferlendirmesi veya ek laboratuvar incelemeleri planlanabilir.<\/p>\n<h2>Testin S\u0131n\u0131rl\u0131l\u0131klar\u0131<\/h2>\n<p>Her laboratuvar testinde oldu\u011fu gibi bu incelemenin de baz\u0131 s\u0131n\u0131rl\u0131l\u0131klar\u0131 vard\u0131r. Sonu\u00e7; \u00f6rnek kalitesi, \u00f6rnekleme zaman\u0131, ta\u015f\u0131ma ko\u015fullar\u0131 ve klinik ba\u011flamdan etkilenebilir.<\/p>\n<ul>\n<li>Tek bir laboratuvar sonucu, klinik \u00e7er\u00e7eve d\u0131\u015f\u0131nda eksik yorumlanabilir.<\/li>\n<li>Uygun olmayan numune kalitesi sonucun g\u00fcvenilirli\u011fini azaltabilir.<\/li>\n<li>Gerekti\u011finde ek testler olmadan tek ba\u015f\u0131na karar vermek yan\u0131lt\u0131c\u0131 olabilir.<\/li>\n<\/ul>\n<h2>Olas\u0131 Riskler<\/h2>\n<p>Risk \u00e7o\u011funlukla numune alma ve numune y\u00f6netimi s\u00fcreci ile ili\u015fkilidir. Testin kendisinden \u00e7ok, \u00f6rne\u011fin al\u0131nmas\u0131 ve uygun ko\u015fullarda \u00e7al\u0131\u015f\u0131lmas\u0131 \u00f6nem ta\u015f\u0131r.<\/p>\n<ul>\n<li>ACE inhibit\u00f6r\u00fc kullanan hastalarda serum ACE d\u00fczeyi d\u00fc\u015f\u00fck olaca\u011f\u0131ndan test anlaml\u0131 de\u011fildir; bu ila\u00e7lar\u0131n kullan\u0131l\u0131p kullan\u0131lmad\u0131\u011f\u0131 mutlaka sorgulanmal\u0131d\u0131r.<\/li>\n<li>\u00c7ocuklarda ve adolesanlarda ACE d\u00fczeyi fizyolojik olarak y\u00fcksektir; yeti\u015fkin referans de\u011ferleri kullan\u0131lmamal\u0131d\u0131r.<\/li>\n<li>ACE d\u00fczeyi sarkoidoz i\u00e7in ne tam duyarl\u0131 ne de tam \u00f6zg\u00fcd\u00fcr; klinik, radyolojik ve histopatolojik verilerle birlikte de\u011ferlendirilmelidir.<\/li>\n<li>Genetik polimorfizm (ACE gen insersion\/deletion polimorfizmi) bazal ACE d\u00fczeyini etkiler.<\/li>\n<li>Seri \u00f6l\u00e7\u00fcmlerle takip, tek \u00f6l\u00e7\u00fcmden daha de\u011ferlidir.<\/li>\n<li>Hemolizli ve lipemik numuneler sonu\u00e7lar\u0131 etkileyebilir.<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>ACE (Angiotensin Converting Enzim) Laboratuvar Bilgileri Yeni Kod: BIO2459 SUT Kodu: L100880 Eski Kod: B\u01300003 Kategori: Biyokimya Numune T\u00fcr\u00fc: Serum Numune Kab\u0131: Sar\u0131 Kapak \u00c7al\u0131\u015fma G\u00fcn\u00fc: Her g\u00fcn \u00d6nemli Kriter: \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r. Raporlama Tarihi: 3 g\u00fcn sonra 18:00 ACE (Angiotensin Converting Enzim) Testi Nedir? ACE [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"parent":5,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"test_category":"Biyokimya","test_kodu":"BIO2459","numune_turu":"Serum","numune_kabi":"Sar\u0131 Kapak","calisma_gunu":"Her g\u00fcn","onemli_kriter":"\u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.","raporlama_tarihi":"3 g\u00fcn sonra 18:00","numune_red_kriterleri":"","aktarim_kodu":"","loinc_kodu":"","sut_kodu":"L100880","akredite":"","numune_miktari":"","alternatif_ornek":"","numune_alinma_sekli":"","stabilite_ozellikleri":"","calisma_yontemi":"","test_bilgisi":"","footnotes":""},"class_list":["post-2082","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/2082","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/types\/page"}],"replies":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/comments?post=2082"}],"version-history":[{"count":4,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/2082\/revisions"}],"predecessor-version":[{"id":8864,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/2082\/revisions\/8864"}],"up":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/5"}],"wp:attachment":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/media?parent=2082"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}